Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20012355 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasm
Interventions: Drug: Docetaxel - Dose A;   Drug: Anastrozole;   Drug: cyclophosphamide;   Drug: Docetaxel - Dose B;   Drug: Doxorubicin hydrochloride;   Drug: Tamoxifen Citrate;   Drug: Capecitabine - Dose B;   Drug: Capecitabine - Dose A

Indicates status has not been verified in more than two years